Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,070.30
+10.30 (0.97%)
Jun 19, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 131.37 billion as of June 18, 2026. Its market cap has increased by 2.92% in one year.
Market Cap
131.37B
Enterprise Value
124.11B
Revenue
25.52B
Ranking
n/a
PE Ratio
23.32
Stock Price
1,070.30
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 131.37B, an increase of 43.24%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 131.37B | 16.82% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |
| NATCO Pharma | 159.23B |
| Cohance Lifesciences | 158.31B |
| Alembic Pharmaceuticals | 149.98B |
| Strides Pharma Science | 102.39B |
| Sudeep Pharma | 95.21B |
| Akums Drugs and Pharmaceuticals | 92.58B |